SpletFLORHAM PARK, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced it will host a Key Opinion Leader (KOL) Roundtable on Interleukin-12 (IL-12) for analysts, investors and the … SpletNasdaq: PDSB PDS Biotech executive team has demonstrated success in the development and commercialization of leading pharmaceutical products 6 • Senior executive …
QuantumScape - Investor Relations
SpletFind the latest press releases from PDS Biotechnology Corporation Common Stock (PDSB) at Nasdaq.com. PDS Biotechnology Corporation Common Stock (PDSB) Press Releases … Splet12. apr. 2024 · FLORHAM PARK, N.J., April 12, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced it will host a Key Opinion Leader (KOL) Roundtable on Interleukin-12 … card java
PDS Biotechnology Corporation (PDSB) Stock Price, News
Splet10. apr. 2024 · SP Global's (NYSE: SPGI) first quarter 2024 results will be issued on Thursday, April 27, 2024 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com . Douglas L. Peterson, President and CEO; Ewout Steenbergen, Executive Vice President and CFO; and Mark Grant, Senior … SpletAbout PDS Biotechnology Corporation 300 CONNELL DRIVE SUITE 4000, BERKELEY HEIGHTS, New Jersey, 7922, United States +1 800 208-3343 … Spletbusiness development and investor relations Seth Van Voorhees, PhD Chief Financial Officer. Nasdaq: PDSB PDS Biotech’s robust Versamune® -based pipeline is being developed in ... Nasdaq: PDSB Phase 2 NCI-led clinical trial evaluating the triple combination of PDS0101, Bintrafusp alfa and M9241 in advanced HPV-associated cancer … card java panel